BEHANDLUNG ODER PRÄVENTION VON OPERATIONSINDUZIERTER KACHEXIE UND/ODER EXPRESSION VON MYELOIDABGELEITETEN SUPPRESSORZELLEN UND PROINFLAMMATORISCHEN ZYTOKINEN
European patent · EP3256111 · In force
Register entry
- Publication number
- EP3256111
- Application number
- EP16704256
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 15, 2016
- Published
- Dec 20, 2017
- Granted
- Sep 2, 2026
- Protection ends at the latest
- Feb 14, 2036
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61K 31/07 (2006.01)A61K 31/198 (2006.01)A61K 31/202 (2006.01)A61K 31/70 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201562116155 P 13.02.2015
- PCT application
- PCT/EP2016/053156 15.02.2016
- PCT publication
- WO2016/128576 18.08.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 2, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 02.09.2026
Parties
Inventor
HAMILTON-REEVES, Jill
Swawnee, Kansas 66216, US
HOLZBEIERLEIN, Jeffrey M.
Mission Hills, KS 66208, US
YANKEE, Thomas
Overland Park, KS 66213, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.